| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018365 |
| Receipt No. | R000021266 |
| Official scientific title of the study | Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation |
| Date of disclosure of the study information | 2015/07/21 |
| Last modified on | 2018/06/22 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation | |
| Title of the study (Brief title) | Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation | |
| Region |
|
|
| Condition | ||
| Condition | Paroxysmal atrial fibrillation
Renal disease |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the maintenance of sinus rhythm after ganglionated plexus ablation in the end-stage renal disease patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Recurrence within one year from the first ablation |
| Key secondary outcomes | i) Recurrence within one year from the last ablation
ii) Procedure time, fluoroscopic time, complications iii) Pulmonary congestion necessary to extend hospital stay iv) Increase in weight after ablation v) Unscheduled hemodialysis vi) Cerebral infarction, systemic thromboembolism vii) All-cause death, cardiac death, sudden death |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Treatment of ganglionated plexus ablation and pulmonary vein isolation before catheter ablation | |
| Interventions/Control_2 | Treatment of pulmonary vein isolation before catheter ablation | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | a. Hemodialysis patients who is planning to receive treatment of first catheter ablation for paroxysmal atrial fibrillation
b. Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study |
|||
| Key exclusion criteria | a. Patients with non-valvular atrial fibrillation, after open heart surgery
b. NYHA III or IV c. Peritoneal dialysis patients d. Patients who were judged inappropriate by the principal investigator |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshio Furukawa |
| Organization | Osaka General Medical Center |
| Division name | Department of Cardiology |
| Address | 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka |
| TEL | 06-6692-1201 |
| kenkyusien@gh.opho.jp | |
| Public contact | |
| Name of contact person | Yoshio Furukawa |
| Organization | Osaka General Medical Center |
| Division name | Department of Cardiology |
| Address | 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka |
| TEL | 06-6692-1201 |
| Homepage URL | |
| kenkyusien@gh.opho.jp | |
| Sponsor | |
| Institute | Osaka General Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Hyogo College of Medicine
Osaka Rosai Hospital Kansai Rosai Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪府立急性期・総合医療センター(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021266 |